It has been suggested that GP73-specific antibodies might interfere with the ELISA analysis [7], [22], as five studies that used ELISA found no significant elevation of GP73 when comparing the serum levels of HCC patients with their controls [14], [15], [17], [23]. The gene discussed is GOLM1; the disease is hepatocellular carcinoma.